Kong, T., Yu, L., Laranjeira, A. B., He, F., Allen, M. J., & Oh, S. T. (2022). Comprehensive Profiling of Clinical JAK2 Inhibitors in Myeloproliferative Neoplasms. Blood, 140(Supplement 1), 3951-3952. https://doi.org/10.1182/blood-2022-164925
Chicago Style (17th ed.) CitationKong, Tim, LaYow Yu, Angelo BA Laranjeira, Fan He, Maggie J. Allen, and Stephen T. Oh. "Comprehensive Profiling of Clinical JAK2 Inhibitors in Myeloproliferative Neoplasms." Blood 140, no. Supplement 1 (2022): 3951-3952. https://doi.org/10.1182/blood-2022-164925.
MLA (8th ed.) CitationKong, Tim, et al. "Comprehensive Profiling of Clinical JAK2 Inhibitors in Myeloproliferative Neoplasms." Blood, vol. 140, no. Supplement 1, 2022, pp. 3951-3952, https://doi.org/10.1182/blood-2022-164925.
Warning: These citations may not always be 100% accurate.
Visit our Citation Styles guide for help on properly citing sources.
Visit our Citation Styles guide for help on properly citing sources.